London, UK, Boston, MA, 9 November 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing significant unmet needs…
November 09, 2025 09:00 ET | Source: Medera Inc. BOSTON, Nov. 09, 2025 (GLOBE NEWSWIRE) -- Medera Inc. ("Medera"), a…
THE WOODLANDS, Texas, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that new sotagliflozin clinical…
Education Cannot Wait and Geneva Global Hub for Education in Emergencies Call for Sustained Support NEW YORK, Nov. 7, 2025…
INDORE, India, Oct. 9, 2025 /PRNewswire/ -- At Apollo Rajshree Hospitals, a 36-year-old man with severe heart failure has been successfully…
SHARJAH, UAE, Sept. 18, 2025 /PRNewswire/ -- As the leading eco-tourism destination in Sharjah, United Arab Emirates (UAE), Mleiha National Park…
Compared with tirzepatide, Wegovy® (semaglutide 2.4 mg) showed a significant 57% greater reduction in the risk of heart attack, stroke…
BEIJING, Aug. 18, 2025 /PRNewswire/ -- CGTN published an article highlighting Galai Village, Xizang's "First Peach Blossom Village," and its…
ZUG, Switzerland, July 23, 2025 /PRNewswire/ -- Berlin Heals and the C-MIC II Investigators today announced the publication of the C-MIC II…
BENGALURU, India, July 17, 2025 /PRNewswire/ -- India is witnessing an alarming public health crisis with heart attacks increasingly striking…